NHS Breast Screening

Helen Maguire Excerpts

Monday 29th June 2026 Westminster Hall

[Helen Maguire (Epsom and Ewell) (LD)]

It is a pleasure to serve under your chairship, Mr Vickers. I thank the hon. Member for North Ayrshire and Arran (Irene Campbell) for leading this important petition debate on NHS breast screening.

It is hard to follow the passionate speech by the hon. Member for Mid Cheshire (Andrew Cooper), but this is important, because there are about 60,000 new cases of breast cancer in the UK each year. Breast cancer represents 15% of all new cancer cases and 30% of all new female cancer cases. It is the most common type of cancer among women: a woman is diagnosed with breast cancer every nine minutes and there are approximately 11,200 deaths due to breast cancer each year in the UK. The human costs behind those statistics cannot be overstated. In the short span of today’s debate, 10 women will be diagnosed with breast cancer and two will tragically lose their lives to the disease.

Over recent decades, we have made huge strides in the diagnosis and treatment of breast cancer. It is remarkable that approximately 76% of women now survive for 10 years or more following their diagnosis. But as with any cancer, diagnosing breast cancer early remains vital and saves lives. Breast screening remains the most effective way to detect cancer at an early stage, which is also when treatment is most likely to succeed. More than 95% of people diagnosed at stage 1 will survive for at least five years, compared with about 25% diagnosed at stage 4.

The Marmot review estimated that the current screening programme prevents about 1,300 deaths a year. In 2024-25, about 2.75 million women aged 50 to 71 were invited to be screened—a 10% increase on the previous year—and 2.15 million of them took the offer up. Nearly 20,000 women had breast cancer detected through that screening, but as those figures highlight, around 600,000 women did not take up the essential offer of breast cancer screening.

Recent screening data reveals an alarming trend of women not attending their first screening appointment. The impact of not taking up the screening offer only compounds the issue. Women who do not attend their first breast cancer screening appointment are much less likely to take up subsequent screening invitations. In 2024-25, only 20.9% of women in England who had never previously taken up screening invitations attended, compared with the 89.1% uptake among women who had been screened in the last five years. Since the creation of the modern NHS breast screening programme, uptake for first-time screening invitations has never reached 70%.

Had the screening uptake level reached the NHS achievable standard target of 80% in 2024-25, over a quarter of a million more women would have undergone routine screening, and that would have resulted in an estimated additional 2,228 cases of breast cancer being found. The scale of the missed opportunity to catch more cancer early is unacceptable, and women and their loved ones are paying the tragic price. I urge anyone who is eligible to take up the offer of breast cancer screening.

The Liberal Democrats are clear that so much more must be done to ensure that every eligible woman attends screening when invited, particularly in England, where uptake is lagging behind the devolved nations and pre-pandemic levels. There are many reasons why women do not attend their breast cancer screening appointments, including misconceptions about the screening process and breast cancer, the fear of receiving a diagnosis, and cultural beliefs and attitudes. Others may not be able to attend due to everyday challenges such as limited transport, clashing work schedules or the burden of caring responsibilities. Health inequalities also affect screening uptake. Women from ethnic minority communities, those living in disadvantaged areas and women with disabilities often face additional barriers that reduce their access to breast screening services.

What actions are the Labour Government taking to improve screening uptake nationally, particularly among disenfranchised women? What steps are the Government actively taking to support pop-up screening initiatives in community settings, and what is being done to ensure that those vital health services are meeting people where they are and at times that work for them? What steps is the Minister taking to ensure that women are able to receive the best screening test for their individual health needs? That might include, for example, providing women with an increased risk of breast cancer with an ultrasound if they are unable to have an MRI or they have dense breasts. That is particularly relevant to younger women with an increased risk, for whom an ultrasound will provide greater accuracy in screening their dense breast tissue. Mammograms can struggle to identify cancer in dense breasts, as cancers and dense tissue present in exactly the same way on imaging.

The Liberal Democrats are also very concerned that so much NHS equipment, including diagnostic and scanning equipment, is out of date and decrepit. A quarter of England’s 280 radiotherapy machines are now operating beyond their 10-year lifespan, with a further 26 due to exceed the recommended lifespan by 2027. England has fewer radiotherapy machines than comparable European countries. Radiotherapy UK’s research reveals that England has just 4.8 linear accelerator machines per million population, well behind France at 8.5 and Italy at 6.9.

Radiotherapy lacks clear accountability. While responsibility for commissioning it sits with integrated care boards, freedom of information requests found that around 70% of ICBs do not have a named person responsible for radiotherapy. Access to radiotherapy is well below international expectations. Around 52% to 53% of cancer patients are estimated to need radiotherapy, but only around 35% receive it in England. In some areas, the figure is as low as 22%. Radiotherapy also has the longest waiting times. Only around four in 10 patients—and, in some areas of the country, as few as two in 10— receive radiotherapy on time.

Whether it is radiotherapy deserts or the mammogram machine glitch that left 7,000 women in parts of Essex without a screening service for almost two months, breast cancer patients are routinely being let down by faulty and inaccessible equipment. That is unacceptable and we must take action now. To address that, the Liberal Democrats are campaigning for a 10-year capital investment programme, under which all patients, including women with breast cancer, would benefit from easier access to newer, quicker and more accurate machines.

Alongside screening, speed and quality of treatment are central to increasing breast cancer survival rates. The Liberal Democrats would introduce a guarantee that 100% of patients would be able to start treatment within 62 days of urgent referral. We would also replace the ageing radiotherapy machines and increase their numbers to guarantee that no one must travel ridiculous distances to receive the treatment that they desperately need. Currently, 3.4 million people in England live further away from a radiotherapy centre than the NHS target of 45 minutes.

Taking those steps now is vital. We need to prepare our local cancer services for the future, as demand is increasing. Cancer cases are expected to rise by about 30% by 2040, and the new national screening programme is likely to identify more patients who need curative radiotherapy treatment. Without urgent action, the existing pressures on radiotherapy services will only worsen. We would also recruit more cancer nurses so that every patient had a dedicated specialist supporting them throughout their treatment, and halve the time for new treatments to reach patients by expanding the capacity of the Medicines and Healthcare products Regulatory Agency.

The future looks bright, with early pilots and trials using AI to analyse mammograms showing promising signs of potential improvement in both the speed and the accuracy of screening, but we must support our life sciences sector much more to champion vital research and innovation. The Liberal Democrats would pass a cancer survival research Act requiring the Government to co-ordinate and ensure funding for research into the cancers with the lowest survival rates.

I want to reflect on the 10 women who were diagnosed with breast cancer and the two who will have tragically lost their lives to the disease in the short span of today’s debate. For them and the thousands of people—mostly women, but also men—living with breast cancer and their loved ones, I urge the Minister to carefully consider the important points and perspectives raised in the debate.